- Home
- RGNX vs SENS Comparison
RGNX vs SENS Comparison
Compare RGNX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- SENS
- Stock Information
- Founded
- RGNX 2008
- SENS 1996
- Country
- RGNX United States
- SENS United States
- Employees
- RGNX N/A
- SENS N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- SENS Industrial Machinery/Components
- Sector
- RGNX Health Care
- SENS Industrials
- Exchange
- RGNX Nasdaq
- SENS Nasdaq
- Market Cap
- RGNX 424.8M
- SENS 396.0M
- IPO Year
- RGNX 2015
- SENS N/A
- Fundamental
- Price
- RGNX $8.70
- SENS $0.49
- Analyst Decision
- RGNX Strong Buy
- SENS Strong Buy
- Analyst Count
- RGNX 8
- SENS 3
- Target Price
- RGNX $31.75
- SENS $1.80
- AVG Volume (30 Days)
- RGNX 788.1K
- SENS 6.4M
- Earning Date
- RGNX 07-31-2025
- SENS 08-07-2025
- Dividend Yield
- RGNX N/A
- SENS N/A
- EPS Growth
- RGNX N/A
- SENS N/A
- EPS
- RGNX N/A
- SENS N/A
- Revenue
- RGNX $156,718,000.00
- SENS $23,682,000.00
- Revenue This Year
- RGNX $327.08
- SENS $60.14
- Revenue Next Year
- RGNX N/A
- SENS $36.55
- P/E Ratio
- RGNX N/A
- SENS N/A
- Revenue Growth
- RGNX 80.70
- SENS 1.64
- 52 Week Low
- RGNX $5.04
- SENS $0.25
- 52 Week High
- RGNX $15.36
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- RGNX 48.91
- SENS 43.22
- Support Level
- RGNX $8.39
- SENS $0.49
- Resistance Level
- RGNX $9.27
- SENS $0.51
- Average True Range (ATR)
- RGNX 0.53
- SENS 0.02
- MACD
- RGNX 0.03
- SENS 0.00
- Stochastic Oscillator
- RGNX 59.86
- SENS 36.93
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.